Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Dadant & Sons Inc
FDA Inspection
•Dadant & Sons Inc•August 15, 2023

Dadant & Sons Inc – FDA Inspection, Aug 15, 2023

Record Details

This FDA Inspection record concerns Dadant & Sons Inc, with an inspection on August 15, 2023, issued by the San Francisco District Office.

Company
Dadant & Sons Inc
Inspection Date
August 15, 2023
Office
San Francisco District Office
Person
  • State Agency
View Company Profile

ID · eabb5ca6-efbb-4898-a98f-47c542b8b9ce

Inspection Facts

Inspection number
1211592
FDA center
Animal Drugs & Feeds
Outcome
Form 483 issued

Other FDA inspections of Dadant & Sons Inc

1
DateClassificationOfficeProject area
June 4, 2019NAICenter for Veterinary MedicineMonitoring of Marketed Animal Drugs, Feed, and Devices
Other documents for Dadant & Sons Inc
  • FDA Inspection 1093910 - 2019-06-04

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dadant & Sons Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.